Javascript must be enabled to continue!
Terlipressin-Associated Complete Heart Block
View through CrossRef
ABSTRACT
Terlipressin has been recently approved in the United States to treat hepatorenal syndrome, a feared complication of both acute and chronic liver diseases. Side effects of the medication have been studied through clinical trials and the precedent use in Europe, as well as extrapolation from its analog vasopressin. As its use is becoming more prevalent, unforeseen complications have arisen. We report a case of complete heart block associated with terlipressin use in presumed hepatorenal syndrome in acute liver injury.
Ovid Technologies (Wolters Kluwer Health)
Title: Terlipressin-Associated Complete Heart Block
Description:
ABSTRACT
Terlipressin has been recently approved in the United States to treat hepatorenal syndrome, a feared complication of both acute and chronic liver diseases.
Side effects of the medication have been studied through clinical trials and the precedent use in Europe, as well as extrapolation from its analog vasopressin.
As its use is becoming more prevalent, unforeseen complications have arisen.
We report a case of complete heart block associated with terlipressin use in presumed hepatorenal syndrome in acute liver injury.
Related Results
Terlipressin in Hepatorenal Syndrome
Terlipressin in Hepatorenal Syndrome
Objective: To compare the pharmacology, dosing, and adverse reactions of vasopressin and terlipressin for the treatment of hepatorenal syndrome (HRS) and assess the efficacy of the...
Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: A randomized study
Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: A randomized study
AbstractBackground: Therapeutic paracentesis in patients with cirrhosis induces arterial vasodilatation, causes a decrease in effective arterial blood volume and leads to circulat...
Clinical Outcomes of Terlipressin Using Continuous Infusion Versus Bolus in Patients With Acute Variceal Hemorrhage–A Randomized Controlled Trial
Clinical Outcomes of Terlipressin Using Continuous Infusion Versus Bolus in Patients With Acute Variceal Hemorrhage–A Randomized Controlled Trial
Goals:
To compare clinical outcomes of terlipressin as continuous versus bolus infusion for the management of acute variceal hemorrhage.
...
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment
Objective
To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal...
Terlipressin for the treatment of hepatorenal syndrome: a meta-analysis of randomized controlled trials
Terlipressin for the treatment of hepatorenal syndrome: a meta-analysis of randomized controlled trials
Objective
This study aimed to evaluate the efficacy and safety of terlipressin and albumin in patients with hepatorenal syndrome.
Meth...
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Abstract
Introduction
The exact manner in which large language models (LLMs) will be integrated into pathology is not yet fully comprehended. This study examines the accuracy, bene...
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
Congenital heart diseases (CHDs) are the structural abnormalities that may occur in the heart, greater veins and arteries or may include the septum between the ventricles and atria...
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Abstract
Background
Women with heart disease undergoing pregnancy is on the increase, along with an increasing cardiac contribut...

